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ProliferationThe retinal pigment epithelium (RPE) plays an essential role in the survival and function of the neural retina.
RPE uncontrolled proliferation leads to the development of proliferative ocular pathologies, among which
proliferative vitreoretinopathy (PVR) is the main cause of retinal surgery failure. Upon the breakdown of the
BRB due to trauma or metabolic imbalance the contact of RPE with serum-contained thrombin has been
shown to stimulate the proliferation of otherwise quiescent RPE cells. Although the molecular mechanisms
involved in this effect are still undetermined, thrombin proteolytic activation of protease-activated G protein
coupled receptor-1 (PAR-1) activates PI3K and Akt, known to play an essential role in proliferation. The
present study demonstrates that: 1) thrombin stimulates Ser 473 Akt phosphorylation without affecting Thr
308 basal phosphorylation in RPE cells; 2) thrombin-induced Akt stimulation promotes cyclin D1
accumulation through the phosphorylation/ inhibition of GSK-3β, thus preventing Thr 286 cyclin D1
phosphorylation, nuclear export and degradation; 3) Akt signaling requires the upstream activation of PI3K
and PLC. Since the pharmacological inhibition of these pathways or the silencing of cyclin expression prevent
thrombin-induced RPE cell proliferation, these results contribute relevant evidence for establishing the
mechanism involved in the development of proliferative eye diseases.: +52 55 5622 5607.
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The retinal pigment epithelium (RPE) is a monolayer of differen-
tiated cells located between the neural retina and the choroidal
vasculature which performs essential functions for the survival of
retinal neurons and the maintenance of the visual process [1]. Among
its functions, RPE contributes to the formation of the blood-retina
barrier (BRB), which in addition to maintaining ionic homeostasis at
the subretinal space prevents the access of proteins and blood
components to the neural retina. Several pathological insults
involving the alteration of the BRB expose RPE to serum components
[2,3] including thrombin, a serine protease known to play a central
role in the coagulation cascade. Thrombin has been shown to
participate in a display of cellular responses such as the promotion
of growth factor secretion, neural cell survival and apoptosis,
cytoskeleton rearrangements and cell proliferation in several cell
types [4,5]. Although RPE cells are mitotically inactive under
physiological conditions, the contact of RPE with serum-contained
thrombin upon the breakdown of the BRB could be involved in the
dedifferentiation, proliferation and migration of RPE cells, central
phenomena in the pathogenesis of proliferative vitreoretinopathy(PVR), the major cause of failure in retinal surgery aimed to the
correction of retinal detachment or severe ocular trauma [6].
Thrombin exerts its actions by activating a small family of G
protein-coupled receptors (GPCRs) named Protease-Activated Re-
ceptors (PARs), by the proteolytic cleavage of a speciﬁc N-terminal
receptor sequence which unmasks a fresh N-terminal that functions
as an intramolecular ligand, thus activating PARs and the receptor-
coupled G proteins. Four members of the PAR family have been
described: PAR-1, PAR-3, and PAR-4, activated by thrombin, and PAR-
2 activated by trypsin, tryptase, and other trypsin-like proteases. PAR-
1, the prototype of this family, signals through Gq11α, G12/13α, and Giα
G proteins, which accounts for the pleiotropic action of its ligands [7].
PAR-mediated activation of Gq induces an increase in intracellular
inositol-trisphosphate (IP3) and calcium, and the downstream
activation of protein kinase C (PKC), phosphoinositide-3 kinase
(PI3K), and mitogen-activated protein kinases (MAPKs). The activa-
tion of PARs is also coupled to the inhibition of adenylyl cyclase via Giα
G proteins and, more recently, PAR-1 coupling to G12/13 activationwas
identiﬁed, although the downstream modulation of G12/13 effectors
such as Rho GTPase and guanine nucleotide exchange factors (GEFs)
by PAR-1 stimulation remains largely undeﬁned [8].
PAR-1 stimulation has been shown to promote intracellular
signaling through the activation of the MAPK ERK1/2, PKC and PI3K
cascadeswhich are involved in the regulation of the cell cycle regulator
cyclin D1 [9]. Particularly, thrombin activation of PI3K family of lipid
kinases through a Gβγ subunit-dependent mechanism [10] results in
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downstream stimulation of Protein Kinase B (Akt/PKB), known to be
involved in the development of proliferative diseases [11,12].
Based on their speciﬁcity, structure and regulation, PI3Ks are
grouped in three classes [13]. Class I PI3Ks are heterodimeric enzymes
which generate phosphatidylinositol-3,4,5-trisphosphate (PIP3) from
phosphatidylinositol-4,5-bisphosphate (PI-4,5-P2), whereas the mo-
nomeric PI3Ks in class II generate phosphatidylinositol-3,4-bispho-
sphate (PI-3,4-P2) and those in class III generate PI-3,4-P2 and PIP3in
vivo. The class I PI3K family includes two subfamilies: class IA,
activated by receptor tyrosine kinases (RTKs), and class IB, activated
by GPCR-dependent signaling [14].
Distinct growth factors and hormones induce the translocation of
PI3K catalytic subunit to the plasma membrane [15] where the
phosphorylation of membrane phosphatidylinositol at the C3-OH
position of the inositol ring is known to anchor proteins containing
plekstrin homology (PH) domains such as Akt/ PKB and PDK1. The full
activation of Akt requires the phosphorylation of Thr 308, located in the
activation loop, and of Ser 473, located in the C-terminal region [15].
While PDK1 has been shown to phosphorylate Thr 308, the kinase
responsible for Akt Ser 473 phosphorylation remains undetermined,
although rapamycin-insensitive complex of mammalian target of
rapamycin (mTORC2) seems to be a viable candidate [16–18].
Akt, the main effector of PI3Ks, regulates cell proliferation through
distinct mechanisms that involve the activation of MAPK, GSK-3β, p70
S6K signaling cascades; the activation of transcription factors such as
NFκB, Forkhead and AP-1; and the control of translation by mTORC1
[15,19,20]. Importantly, the PI3K/PDK1/Akt pathway is up-regulated
in proliferative diseases, including cancer [14].
Thrombin has been shown to induce the expression of cyclin D1 in
cortical neurons [21] as well as the proliferation of brain astrocytes
and retinal glia [4,5]. Particularly in RPE cells, the activation of PAR-1
by thrombin promotes cell cycle progression and proliferation by
increasing c-Fos and cyclin D1 expression, mediated by PI3K/ERK1/2
and PLC-β/PKC signaling [22,23]. Also on this line, studies in human
RPE cells have demonstrated that the inhibition of cyclin D1
expression signiﬁcantly prevents serum-induced proliferation [24].
Based on these data, a role for thrombin in the pathogenesis of
proliferative eye disorders such as PVR may be considered.
Our previous work demonstrated that thrombin stimulation in-
creases cyclin D1 gene expression and proliferation of RPE cells [23]. In
addition togeneexpression, cyclinD1 concentration is under the control
of molecular mechanisms which regulate cyclin degradation [9,20,25].
Among these, glycogen synthase kinase 3β (GSK-3β) is known to
repress cell cycle progression by directly phosphorylating cyclin D1 [19]
and indirectly regulating cyclin D1 transcription by inhibiting Wnt
signalling. Cyclin D1 phosphorylation at Thr 286, promotes cyclin
nuclear-cytoplasmic translocation and rapid degradation [26,27].
To further investigate the molecular mechanism responsible for
thrombin-induced RPE cell proliferation, in the present study we
analyzed the role of PI3K/PDK1/Akt/GSK-3β signaling in thrombin
promotion of cyclin D1 expression and RPE cell proliferation. Our
results demonstrate for the ﬁrst time that thrombin induces the
progression of cell cycle, and the proliferation of RPE cells through the
activation of Akt and the downstream inactivation of GSK-3βwhich in
turn, leads to cyclin D1 stabilization and accumulation.
2. Materials and methods
2.1. Reagents
All reagents used were cell culture grade. Thrombin, hirudin, AG-
1478 and Ro-32-0432were obtained from Calbiochem (San Diego, CA,
USA); AG-1296, wortmannin, triﬂuoperazine and Akt inhibitor were
from Sigma (St. Louis MO, USA); PPACK was from Enzo Life Science
(Farmingdale, NY, USA) OSU was from Echelon biosciences (Salt LakeCity, UT, USA); LY294002, U-73122 and KN62 were from Tocris
(Ellisville, MO, USA). Serum-free Opti-MEM (Invitrogen, Carlsbad, CA,
USA) was used as the standard medium for all assays.
The monoclonal antibodies rabbit anti-Akt, rabbit anti-phospho
Akt Ser 473, rabbit anti-GSK-3β and rabbit anti-phospho GSK-3β Ser 9
were obtained from Cell Signaling Technology (Danvers, MA, USA).
Rabbit anti-phospho Akt Thr 308, mouse anti-cyclin D1, mouse anti-
actin and mouse anti-GAPDH were purchased from Santacruz Biolabs
(Santacruz, CA, USA). Secondary HRP-conjugated anti-rabbit IgG and
HRP-conjugated anti-mouse IgG antibodies were from Zymed
Laboratories (San Francisco, CA, USA).
2.2. Cell culture
RPE cells were isolated from 8- to 10-day-old Long Evans rat, as
previously described [28]. Brieﬂy, the eyes were enucleated, rinsed in
Dulbecco modiﬁed Eagle medium (DMEM) containing 0.0125%
penicillin and streptomycin, 0.025% neomycin, and 0.01% nystatin
(Gibco BRL), and incubated in DMEM containing 2% dispase for 30 min
at 37 °C. After removal of the sclera, RPEwas detached in calcium- and
magnesium-free Hanks’ balanced salt solution (HBSS), incubated in
the presence of 0.1% trypsin-EDTA (Gibco) for 2 min, and mechani-
cally dissociated using a Pasteur pipette. Trypsin digestion was
stopped by 4% fetal bovine serum (FBS, Gibco BRL). Cells were
separated by centrifugation, suspended in Opti-MEM plus 4% FBS, and
seeded in six-well plates at 3×104cells/cm2 density. After 4 days in
culture, cells were serum-deprived for 48 h prior to stimulation with
thrombin (0–4 U/ml), in order to synchronize the cells. The effect of
serum deprivation on RPE cell viability was assessed by trypan blue
exclusion. Cell viability in serum-deprived vs. control cultures in
serum-containing medium was≥90%. All experiments were per-
formed in synchronized cultures.
2.3. RPE cell proliferation
RPE cell proliferation was determined by [3H] thymidine incorpo-
ration and the colorimetric MTS [(3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl) -2H- tetrazolium] reduc-
tion method in non-conﬂuent cultures, as previously described [22,23].
Cells were incubated for 24 h with 0.2 μCi/ml [3H] thymidine (Perki-
nElmer; 16 Ci/mmol) in the absence (control) or presence of thrombin.
After washing in PBS, cultureswere added trichloroacetic acid (10%) for
1 h, solubilized in 0.5% sodium dodecyl sulfate (SDS), and counted for
radioactivity in a liquid scintillation counter (Beckman). Proliferation
was also assessed by MTS reduction method (Cell Titer 96® Aqueous
One Solution Reagent, Promega) following the manufacturer's in-
structions. Absorbance at 490/630 nm was corrected for background,
and the optical density (OD) from non-stimulated cultures was
arbitrarily set as 100% (basal) proliferation. When tested, inhibitors
were added 1 h prior to thrombin stimulation.
2.4. Western blot analysis
Cells were disrupted in lysis buffer containing 50 mM Tris–HCl pH
7.4, 150 mMNaCl, 10 mM EDTA, 0.1% SDS, 1%, Triton X-100, 1% CHAPS,
0.5% NP40, 0.1% BSA, 40 mM β-glycerophosphate, 10 mM sodium
pyrophosphate, and 10% of a protease inhibitor cocktail (SIGMA).
Protein in the lysateswas quantiﬁed using the Bradfordmethod and
20 μg of the total protein was used for protein immunodetection
analysis. The lysates were solubilized in Laemmli buffer (0.75 mMTris–
HCl; pH 8.8, 5% SDS, 20% glycerol and 0.01% bromophenol blue), boiled
for 5 min, resolved by SDS/PAGE (12.5%), and transferred onto
polyvinyldiene diﬂuoride (PVDF)membranes (AmershamBiosciences).
After blocking for 1 h at room temperature with 5% non-fat milk in
Tween TBS, the PVDFmembraneswere probedwith primary antibodies
against Akt (1:1000), phospho Akt Ser 473 (1:1000), phospho Akt Thr
Fig. 1. Thrombin stimulates Ser 473 Akt phosphorylation. Cells were cultured as described in Materials and methods and stimulated with 4 U/ml thrombin. Relative Akt
phosphorylation was determined by Western blot. Thrombin induced the time-dependent phosphorylation of Akt on Ser 473. Thr 308 Akt phosphorylation level was unaffected by
thrombin treatment. Results are expressed as the mean±SEM of three independent experiments. ** Pb0.01, Student's t-test, compared to control.
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(1:3000) at 4 °C for 24 h. Secondary HRP-conjugated antibody (1:5000)
was included for 1 h and membranes were developed using the
Immobilon Western AP Chemiluminescent Substrate (Millipore, Biller-
ica, MA, USA). Kodak® ﬁlm images were digitized using an Alpha Digi-
Doc system (Alpho-Innotech, San Leandro, CA, USA), and densitometric
analysis was performed using the Quantity One Software v4.6 from
BioRad (Hercules, CA, USA) and normalized to control values. GAPDH
immunodetection was used as loading control.
2.5. Cyclin D1 silencing
Cyclin D1 small interfering RNA (siRNA) was purchased from
Sigma (SASI_Rn02_00269089). The effect of cyclin D1 knockdownFig. 2. Thrombin induces the speciﬁc, dose-dependent phosphorylation of Akt on Ser 473. R
phosphorylation in a dose-dependent manner. B. Inactivation of thrombin by hirudin (8 U/
phosphorylation. Results are expressed as the mean±SEM of three independent experimeon RPE cell proliferation was tested in 30–50% conﬂuent cultures.
Transfection of siRNA was performed using Lipofectamine RNAi-
MAX reagent (Invitrogen, Carlsbad, CA, USA) in antibiotic-free 4%
FBS-supplemented Opti-MEM medium for 48 h. Following trans-
fection, cell proliferation was assessed by the MTS reduction
method. Cyclin D1 silencing was determined by western blot.
Lipofectamine-treated and non-treated cells were used as controls.2.6. Statistical analysis
Raw data for analysis were obtained from pooled RPE cells of
10–15 Long Evans Rats in three independent experiments. Unpaired
Student t-test was applied for statistical analysis, using the PrismPE cells were exposed to 4 U/ml thrombin for 30 min. A. Thrombin induced Ser 473 Akt
ml) or by the catalytic blocker PPACK (25 μM) prevents thrombin-induced Ser 473 Akt
nts. * Pb0.05, ** Pb0.01, Student's t-test, compared to control.
Fig. 3. Thrombin-induced Ser 473 Akt phosphorylation involves the activation of EGF
and PDGF receptors. Cells were stimulated with thrombin (4 U/ml) in presence or
absence of speciﬁc inhibitors for EGF (AG-1478, 10 μM) and PDGF (AG-1296, 10 μM)
receptor activity. The inhibition of EGF and PDGF receptors prevented thrombin-
induced Ser 473 Akt phosphorylation. Results are expressed as the mean±SEM of three
independent experiments. ** Pb0.01, Student's t-test, referred to control. @ Pb0.05,
Student's t-test, referred thrombin-stimulated cells.
Fig. 4. Thrombin-induced Akt activation requires PI3K activity. Cells were exposed to 4
wortmannin (100 nM) and LY294002 (10 μM). The inhibition of PI3K prevented thromb
independent experiments. * Pb0.05, ** Pb0.01, *** Pb0.001 Student's t-test, compared to c
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mined using Student's t-test.3. Results
3.1. Thrombin increases Akt phosphorylation/activation in RPE cells
The effect of thrombin on the phosphorylation of Akt at Thr 308
and Ser 473 was analyzed. As depicted in Fig. 1, exposure of
cultured cells to 2 U/ml thrombin results in a signiﬁcant increase in
Ser 473 Akt phosphorylation, reaching a plateau from 30 to 45 min
and gradually decreasing thereafter. In contrast, the phosphoryla-
tion level of Akt Thr 308 was not modiﬁed by this treatment (Fig. 1).
Exposure of RPE cells to increasing concentrations of thrombin
revealed a clear dose-dependence of Ser 473 Akt phosphorylation
(Fig. 2A), indicating the speciﬁcity of the effect. This result was
further conﬁrmed by the inhibition of this effect by the inactivation
of thrombin by its natural inhibitor hirudin, or by the catalytic
inhibitor PPACK prior to addition to the cultures (Fig. 2B). These
results demonstrate that thrombin stimulates the phosphorylation
of Akt at Ser 473 in a speciﬁc, dose-dependent manner, without
modifying Thr 308 basal level of phosphorylation.
Thrombin has been shown to promote the transactivation of
growth factor receptors in RPE cells [29]. In order to establish
whether thrombin-induced Akt activation depends on VEGF and
PDGF receptor transactivation, we tested the effect of speciﬁc
receptor inhibitors on thrombin-induced Ser 473 Akt phosphory-
lation. Our results showed that Akt phosphorylation requires VEGF
and PDGF receptor activation (Fig. 3).U/ml thrombin in the absence (control) or presence of the speciﬁc PI3K inhibitors
in-induced Akt phosphorylation. Results are expressed as the mean±SEM of three
ontrol.
Fig. 5. Akt activation by thrombin is unrelated to c/n PKC isoforms and CaMKII. RPE cells were stimulated with 4 U/ml thrombin, and Thr 308 and Ser 473 Akt phosphorylation was
assessed in the absence (control) or presence of speciﬁc enzyme inhibitors: U-73122 for PLC (2.5 nM); Ro-32-0432 for c/nPKC (20 μM), for calmodulin (triﬂuoperazine [TFP] 50 μM)
and for CaMKII (KN-62, 5 μM). The inhibition of PLC and calmodulin signiﬁcantly decreased the basal level of Thr 308 and Ser473 Akt phosphorylation, as well as thrombin-
stimulated Ser473 phosphorylation. Inhibition of c/nPKC and CamKII had no effect on Akt phosphorylation. Results are expressed as the mean±SEM of three independent
experiments. ** Pb0.01, Student's t-test, compared to control. @ Pb0.01, Student's t-test, compared to thrombin-stimulated cells.
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calmodulin signaling
The phosphorylation of Akt at Ser 473 has been suggested to
require the prior phosphorylation of Thr 308 by PI3K/PDK1 [15,17].
Since thrombin did not modify Thr 308 phosphorylation, we asked if
PI3K-dependent maintenance of basal Thr 308 phosphorylation is
required for the further phosphorylation of Ser 473. To this end, we
tested the effect of the PI3K inhibitors wortmannin and LY294002 on
Akt phosphorylation. Results in Fig. 4 show that wortmannin reduced
the basal phosphorylation of Thr 308 by 55.4%, and also inhibited, by
70.1%, thrombin-induced Akt phosphorylation at Ser 473. The
addition of LY294002 abolished both, the basal phosphorylation of
Thr 308 and thrombin-induced Akt phophorylation at Ser 473 (Fig. 4),
indicating that induction of Ser 473 phosphorylation requires Thr 308
phosphorylated Akt.
Calcium/calmodulin-dependent kinases, PKC and PLC have been
implicated in thrombin-induced signaling to Akt [17]. The possible
contribution of these pathways to thrombin-induced Akt phosphor-
ylation was tested by the pharmacologic inhibition of calmodulin by
triﬂuoperazine (50 μM), of CaMKII by KN-62 (5 μM), of c/nPKC by Ro-
32-0432 (20 μM), and of PLC by U-73122 (2.5 nM). Results showed
that CaMKII and c/nPKC isoforms are not involved in thrombin-
induced Akt phosphorylation; in contrast, the inhibition of PLC or
calmodulin prevented thrombin-induced Ser 473 Akt phosphoryla-tion by 74.9% and 66.5%, respectively (Fig. 5B). Furthermore, the
inhibition of PLC or calmodulin signiﬁcantly decreased the basal level
of Thr 308 phosphorylated Akt (Fig. 5A). Together, these results
indicate the participation of PI3K, PLC and calcium/calmodulin
signaling in thrombin-induced Akt activation.
3.3. Thrombin-induced RPE cell proliferation requires Akt activation
Our previous work showed that thrombin promotes RPE cell
proliferation [22,23]. To investigate if PI3K/PDK1/Akt signaling is
involved in the control of proliferation, we tested the effect of Akt and
PDK1 speciﬁc inhibition on [3H]-thymidine incorporation and MTS
reduction in thrombin-stimulated cells. Our results demonstrate that
the inhibition of Akt or PDK1 prevents thrombin-induced [3H]-
thymidine incorporation and MTS reduction, hence indicating the
inhibition of cell proliferation (Fig. 6A). These results suggest that
thrombin-induced proliferation requires PDK1/Akt activation in RPE
cells.
3.4. Akt mediates thrombin-induced cyclin D1 accumulation
The stimulation of cyclin D1 expression by thrombin in RPE cells
has been reported [23]. In order to establish if cyclin D1 accumulation
depends on PDK1/Akt activity, we analyzed the effect of Akt and PDK1
inhibitors on thrombin-induced cyclin D1 increase. Our results
Fig. 6. Induction of RPE cell proliferation by thrombin requires Akt-mediated cyclin D1 accumulation. Cells were stimulated with 4 U/ml thrombin in the presence or absence of Akt
inhibitor (500 nM) or the PDK1 inhibitor OSU-03-012 (5 μM). A. Proliferation wasmeasured by [3H]-thymidine incorporation (top) or MTT assay (bottom). Inhibition of Akt or PDK1
prevented thrombin-induced RPE cell proliferation. B. Cyclin D1concentration was determined by western blot. Inhibition of Akt or PDK1 prevented cyclin D1 expression. Results are
expressed as the mean±SEM of three independent experiments. *** Pb0.001, Student's t-test, compared to control. @ Pb0.01, # Pb0.001 Student's t-test, relative to thrombin-
stimulated cells.
Fig. 7. RPE cell proliferation requires cyclin D1 expression. A. RPE cells were transfected with cyclin D1 siRNA, and cyclin D1 level was determined after 72 h by western blot.
Proliferation was measured following 24 h thrombin treatment. Cyclin D1 siRNA decreased thrombin-stimulated cyclin D1 protein expression by 70%. B. Thrombin-induced RPE cell
proliferation measured by [3H]-thymidine incorporation, was prevented by silencing cyclin D1 expression. Non-transfected and lipofectamine-treated cells were used as controls.
Results are expressed as the mean±SEM of two independent experiments. * Pb0.05, *** Pb0.001 Student's t-test, compared to control.
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Fig. 8. Activation of Akt by thrombin induces GSK3β phosphorylation. RPE cells were stimulated with 4 U/ml thrombin in the absence or presence of speciﬁc inhibitors for Akt (500
nM) and PDK1 (OSU-03-012, 5 μM). Ser 9 GSK3β phosphorylation was determined by Western blot. A. Thrombin induced GSKβ phosphorylation from 45 min up to 480 min
stimulation. B. The Akt inhibitor (500 nM) and the PDK1 inhibitor OSU-03-012 (5 μM) prevented thrombin-induced GSK3β phosphorylation/inactivation in RPE cells. Results are
expressed as the mean±SEM of three experiments. * Pb0.05, ** Pb0.01, *** Pb0.001 Student's t-test, referred to control. @ Pb0.01, Student's t-test, referred thrombin-stimulated
cells.
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increase induced by thrombin (Fig. 6B), suggesting that this signaling
pathway is responsible for RPE proliferation. In order to conﬁrm this
assumption, we asked if thrombin-induced proliferation requires
cyclin D1 gene expression, by silencing cyclin D1 expression using
speciﬁc siRNA. Results depicted in Fig. 6A demonstrate that cyclin D1
silencing by siRNA transfection decreases cyclin D1 protein expres-
sion by 70%. Furthermore, an 86.5% decrease in thrombin-induced RPE
cell proliferation was observed upon cyclin D1 expression silencing
(Fig. 7B). These data demonstrate that thrombin stimulates cell
proliferation by promoting cyclin D1 gene expression.
3.5. Thrombin induces Akt-dependent GSK-3β phosphorylation
In addition to gene expression, Akt signaling may increase cyclin
D1 concentration by distinct molecular mechanisms, including
stabilization [9,20,25]. Glycogen synthase kinase-3β (GSK-3β) re-
presses cell cycle progression by directly phosphorylating cyclin D1
[19] at Thr 286, which promotes its degradation. In order to explore if
thrombin stimulates cyclin D1 accumulation by inactivating GSK-3β,
we examined the inactivation of this enzyme by phosphorylation at
Ser 9. As shown in Fig. 8A increased GSK-3β phosphorylation at Ser 9
was observed following 45 min in the presence of thrombin, which
was sustained up to 480 min. This effect was prevented by the
inhibition of PI3K, PDK1 or Akt (Fig. 8B), suggesting that thrombin
activation of Akt inactivates GSK-3β, hence promoting the stabiliza-
tion of cyclin D1.
4. Discussion
Upon the alteration of the BRB, the interaction of RPE cells with
thrombin contained in blood serum is an important determinant in
the development of proliferative eye disorders generated by theepithelial-mesenchymal transition, proliferation and migration of
RPE cells, and the formation of epiretinal membranes which impair
vision. In fact, intraocular hemorrhage during or after surgery is
among the most important clinical risk factors for the development
of proliferative vitreoretinopathy [30], the major cause of retinal
surgery failure [6]. Although the molecular mechanisms leading to
this outcome have not been established, the activation of Akt/PKB
signaling is a key event in thrombin-induced proliferation of several
cell types [31–33]. The present work was aimed to determine
whether Akt activation is required for thrombin-induced cyclin D1
expression and proliferation in RPE cells.
Our present study demonstrates that, in contrast with ﬁndings
showing that thrombin induces Akt phosphorylation at both Thr
308 and Ser 473 in different cell types [17], this mechanism differs
in RPE cells. Whereas the phosphorylation level of Akt at Thr 308
remains unaltered by thrombin treatment (Fig. 1), Ser 473
phosphorylation was increased in a speciﬁc and dose-dependent
manner (Fig. 2), indicating that Ser 473 phosphorylation is the
regulatory event in thrombin-induced Akt activation in RPE cells.
Our results showed that thrombin stimulation of Ser 473 Akt
phosporylation required 30 min thrombin exposure, which differs
from the fast phosphorylation of Akt observed in response to
tyrosine kinase receptor activation [34,35], suggesting that an
indirect mechanism could mediate PAR-1 signaling to Akt. Based on
recent evidence showing that thrombin induces VEGF secretion in
RPE cells through PAR-1 transactivation of PDGF receptor [29], we
tested the effect of VEGF and PDGF receptor inhibition, and showed
that thrombin stimulates Akt phosphorylation through the trans-
activation of growth factor receptors, which explains the delayed
response of Akt to thrombin (Fig. 3).
PI3K, CaMK and PKC signaling pathways have been implicated in
the regulation of Akt activity [17]. On this matter, thrombin
promotion of PI3K signaling through PAR-coupled G βγ subunits
Fig. 9. Schematic representation of RPE cell proliferation stimulated by thrombin.The
activation of PAR1 stimulates Akt through the parallel activity of PI3K/PDK1 on Thr 308
and that of PLC/CaMKs on Ser 473. While Akt phosphorylates/inactivates GSK3β, the
sustained inhibition of this enzyme, which prevents cyclin D1 degradation, is
conceivably maintained by PKCζ . The increased stability of cyclin D1 prevents nuclear
export thus allowing cell cycle progression and proliferation.
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transcriptional activity in endothelial cells by thrombin is achieved
by the parallel engagement of Gαq/PKC and Gβγ/PI3K signaling
pathways that converge at Akt [33]. We analyzed the possible
contribution of these pathways to thrombin-induced Akt activation
in RPE cells. As expected, the inhibition of PI3K by wortmannin or
LY294002 reduced Akt basal phosphorylation at Thr 308. Surpris-
ingly, thrombin stimulation of Ser 473 Akt phosphorylation was
prevented by PI3K inhibition (Fig. 4), indicating that phosphory-
lated-Thr 308 is required for Ser 473 phosphorylation, in agreement
with recent data obtained in cancer cells [15]. Additionally, the
inhibition of Ser 473 Akt phosphorylation by the inhibition of PI3K
could relate to the decreased formation of PIP3, required for Akt
recruitment to the plasma membrane, prior to activation [37].
Thrombin has been shown to activate PLC in RPE cells [22]. Since
the PLC products, DAG and IP3 (Ca++) are known to stimulate c/nPKCs,
and the calcium/calmodulin-dependent kinases (CaMKs) respec-
tively, we analyzed the contribution of these pathways to the
stimulation of Akt phosphorylation. Our results demonstrate that
whereas PLC inhibition prevented thrombin-induced Ser 473 Akt
phosphorylation, the inhibition of c/nPKC, had no effect (Fig. 5).
Although the participation of the novel PKCδ and PKCθ, which arenot inhibited by Ro-32-0432 [38] cannot be ruled-out, PLC signaling
to Akt seems to involve signals different from DAG-sensitive c/εPKC
isoforms (Fig. 5).
Among the CaMKs activated by PLC-derived calcium increase,
CaMKII has been implicated in Akt activation [39]. We showed that,
although CaMKII does not seem to be involved in thrombin-induced
Akt phosphorylation, the inhibition of calmodulin did prevent
thrombin-induced Ser 473 Akt phosphorylation and also decreased
basal Thr 308 phosphorylation level (Fig. 5), which demonstrates
that PLC-dependent activation of a calcium/calmodulin kinase,
distinct from CaMKII is required for thrombin effect on Akt
activation in RPE cells. On this matter, recent evidence has shown
that Akt is a downstream target for CaMKIII, also known as
eukaryotic elongation factor-2 (eEF-2) kinase [40], and hence,
could be implicated in PLC-induced Akt phosphorylation observed.
Previous studies from our group demonstrated that thrombin-
induced RPE cell proliferation requires cyclin D1 accumulation [23].
We here showed that the inhibition of PDK1 or Akt prevented
thrombin-induced cyclin D1 accumulation (Fig. 6B). Moreover, siRNA
silencing of cyclin D1 expression prevented proliferation (Fig. 7),
conﬁrming that thrombin stimulates proliferation by Akt-dependent
increase in cyclin D1 protein expression. On this line, the inhibition of
DNA synthesis and cell division upon PDK1 and Akt inhibition we
observed (Fig. 6A) are in agreement with previous reports suggesting
that PDK1/Akt signaling is essential for thrombin-induced RPE cell
proliferation [31,41].
In addition to transcriptional control, Akt may contribute to
cyclin D1 nuclear accumulation through the phosphorylation of
GSK-3β on Ser9, which inactivates this enzyme, preventing cyclin
degradation [9,19]. We showed that the stimulation of Akt by
thrombin induces the phosphorylation of GSK-3β (Fig. 8A, B).
Together, these results suggest that the activation of Akt increases
cyclin D1 concentration by two mechanisms: promotion of gene
expression and stabilization of the translated protein.
Although the mechanism by which the transient activation of
Akt Ser 473 (30 to 45 min) induces the sustained phosphorylation
of GSK-3β at Ser 9 up to 480 min stimulation requires further
investigation, our results suggest that while Akt is responsible for
GSK-3β phosphorylation, the phosphorylated state is maintained
through a distinct molecular mechanism. Among the kinases
capable of regulating GSK-3β function, the atypical PKCζ isoform
has recently been shown to phosphorylate GSK-3β at Ser 9 [42].
Since we have shown previously that thrombin-induced cyclin D1
protein expression (unpublished) and RPE cell proliferation require
PKCζ activity [23], it is tempting to speculate that Akt transient
activation induces GSK-3β phosphorylation, whereas the long
lasting activation of PKCζ by thrombin could be responsible for
sustained phosphorylation of GSK-3β and the consequent stabili-
zation of cyclin D1 (Fig. 9).
The activation of Akt/PKB signaling is a key event in thrombin-
induced proliferation of several cell types [4,10,31,32]. Further-
more, this pathway is up-regulated in proliferative pathologies such
as cancer [15,43]. Since proliferation is a key phenomenon in the
development of proliferative eye diseases, our work contributes
information for the development of strategies aimed to the
prevention and treatment of proliferative eye pathologies, which
are a major cause of blindness.
Acknowledgements
This work was partially supported by grants CB-80398 from
CONACyT and IN-200209 from PAPIIT/UNAM to A. M. L. C. This
study is part of the requirements for the PhD degree in Biomedical
Sciences of Alejandro Parrales Briones at the Universidad Nacional
Autónoma de México and was supported by a CONACYT fellowship.
The authors thank Dr. Jose Prisco Palma-Nicolas for collaboration.
1766 A. Parrales et al. / Biochimica et Biophysica Acta 1813 (2011) 1758–1766References
[1] O. Strauss, The retinal pigment epithelium in visual function, Physiol. Rev. 85
(2005) 845–881.
[2] M. Mund, M. Rodrigues, The retinal pigment epithelium, in: K. Zinn, M. Marmar
(Eds.), The Retinal Pigment Epithelium, Harvard University Press, London, 2006,
pp. 45–52.
[3] H. Nagasaki, K. Shinagawa, M. Mochizuki, Risk factors for proliferative
vitreoretinopathy, Prog. Retin. Eye Res. 17 (1998) 77–98.
[4] O. Nicole, A. Goldshmidt, C.E. Hamill, S.D. Sorensen, A. Sastre, P. Lyuboslavsky, J.R.
Hepler, R.J. McKeon, S.F. Traynelis, Activation of protease-activated receptor-1
triggers astrogliosis after brain injury, J. Neurosci. 25 (2005) 4319–4329.
[5] D.G. Puro, T. Mano, C.C. Chan, M. Fukuda, H. Shimada, Thrombin stimulates the
proliferation of human retinal glial cells, Graefes Arch. Clin. Exp. Ophthalmol 228
(1990) 169–173.
[6] J.C. Pastor, E.R. de la Rua, F. Martin, Proliferative vitreoretinopathy: risk factors and
pathobiology, Prog. Retin. Eye Res. 21 (2002) 127–144.
[7] J. Trejo, Protease-activated receptors: new concepts in regulation of G protein-
coupled receptor signaling and trafﬁcking, J. Pharmacol. Exp. Ther. 307 (2003)
437–442.
[8] S.R. Macfarlane, M.J. Seatter, T. Kanke, G.D. Hunter, R. Plevin, Proteinase-activated
receptors, Pharmacol. Rev. 53 (2001) 245–282.
[9] J. Liang, J.M. Slingerland, Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle
progression, Cell Cycle 2 (2003) 339–345.
[10] M. Minhajuddin, K.M. Bijli, F. Fazal, A. Sassano, K.I. Nakayama, N. Hay, L.C.
Platanias, A. Rahman, Protein kinase C-delta and phosphatidylinositol 3-kinase/
Akt activate mammalian target of rapamycin to modulate NF-kappaB activation
and intercellular adhesion molecule-1 (ICAM-1) expression in endothelial cells, J.
Biol. Chem. 284 (2009) 4052–4061.
[11] D. Kong, T. Yamori, Phosphatidylinositol 3-kinase inhibitors: promising drug
candidates for cancer therapy, Cancer Sci. 99 (2008) 1734–1740.
[12] H. Li, I.B. Weinstein, Protein kinase C beta enhances growth and expression of
cyclin D1 in human breast cancer cells, Cancer Res. 66 (2006) 11399–11408.
[13] C.K. Cheng, Q.W. Fan, W.A. Weiss, PI3K signaling in glioma—animal models and
therapeutic challenges, Brain Pathol. 19 (2009) 112–120.
[14] J.A. Engelman, J. Luo, L.C. Cantley, The evolution of phosphatidylinositol 3-kinases
as regulators of growth and metabolism, Nat. Rev. Genet. 7 (2006) 606–619.
[15] A. Carnero, The PKB/AKT pathway in cancer, Curr. Pharm. Des. 16 (2010) 34–44.
[16] J.R. Bayascas, D.R. Alessi, Regulation of Akt/PKB Ser473 phosphorylation, Mol. Cell
18 (2005) 143–145.
[17] J.C. Resendiz, M.H. Kroll, R. Lassila, Protease-activated receptor-induced Akt
activation–regulation and possible function, J. Thromb. Haemost. 5 (2007)
2484–2493.
[18] D.D. Sarbassov, D.A. Guertin, S.M. Ali, D.M. Sabatini, Phosphorylation and
regulation of Akt/PKB by the rictor-mTOR complex, Science 307 (2005)
1098–1101.
[19] D.A. Cross, D.R. Alessi, P. Cohen, M. Andjelkovich, B.A. Hemmings, Inhibition of
glycogen synthase kinase-3 by insulin mediated by protein kinase B, Nature 378
(1995) 785–789.
[20] X.M. Ma, J. Blenis, Molecular mechanisms of mTOR-mediated translational
control, Nat. Rev. Mol. Cell Biol. 10 (2009) 307–318.
[21] H.V. Rao, L. Thirumangalakudi, P. Desmond, P. Grammas, Cyclin D1, cdk4, and Bim
are involved in thrombin-induced apoptosis in cultured cortical neurons, J.
Neurochem. 101 (2007) 498–505.
[22] J.P. Palma-Nicolas, E. Lopez, A.M. Lopez-Colome, PKC isoenzymes differentially
modulate the effect of thrombin on MAPK-dependent RPE proliferation, Biosci
Rep. 28 (2008) 307–317.
[23] A. Parrales, J.P. Palma-Nicolas, E. Lopez, A.M. Lopez-Colome, Thrombin stimulates
RPE cell proliferation by promoting c-Fos-mediated cyclin D1 expression, J. Cell.
Physiol. 222 (2010) 302–312.[24] C. Hecquet, G. Lefevre, M. Valtink, K. Engelmann, F. Mascarelli, Activation and role
of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and
RPE cell proliferation, Invest Ophthalmol. Vis Sci. 43 (2002) 3091–3098.
[25] W. Ouyang, J. Li, Q. Ma, C. Huang, Essential roles of PI-3K/Akt/IKKbeta/NFkappaB
pathway in cyclin D1 induction by arsenite in JB6 Cl41 cells, Carcinogenesis 27
(2006) 864–873.
[26] J.R. Alt, J.L. Cleveland, M. Hannink, J.A. Diehl, Phosphorylation-dependent
regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular
transformation, Genes Dev. 14 (2000) 3102–3114.
[27] J.A. Diehl, M. Cheng, M.F. Roussel, C.J. Sherr, Glycogen synthase kinase-3beta
regulates cyclin D1 proteolysis and subcellular localization, Genes Dev. 12 (1998)
3499–3511.
[28] C.W. Chang, R.S. Roque, D.M. Defoe, R.B. Caldwell, An improved method for
isolation and culture of pigment epithelial cells from rat retina, Curr. Eye Res. 10
(1991) 1081–1086.
[29] M. Hollborn, C. Petto, A. Steffen, S. Trettner, A. Bendig, P.Wiedemann, A. Bringmann,
L. Kohen, Effects of thrombin on RPE cells are mediated by transactivation of growth
factor receptors, Invest Ophthalmol. Vis Sci. 50 (2009) 4452–4459.
[30] P. Girard, G. Mimoun, I. Karpouzas, G. Monteﬁore, Clinical risk factors for
proliferative vitreoretinopathy after retinal detachment surgery, Retina 14 (1994)
417–424.
[31] H. Cao, N. Dronadula, G.N. Rao, Thrombin induces expression of FGF-2 via
activation of PI3K-Akt-Fra-1 signaling axis leading to DNA synthesis and motility
in vascular smooth muscle cells, Am J Physiol. Cell Physiol. 290 (2006)
C172–C182.
[32] S. Kim, J. Jin, S.P. Kunapuli, Akt activation in platelets depends on Gi signaling
pathways, J. Biol. Chem. 279 (2004) 4186–4195.
[33] A. Rahman, A.L. True, K.N. Anwar, R.D. Ye, T.A. Voyno-Yasenetskaya, A.B. Malik,
Galpha(q) and Gbetagamma regulate PAR-1 signaling of thrombin-induced NF-
kappaB activation and ICAM-1 transcription in endothelial cells, Circ. Res. 91
(2002) 398–405.
[34] S.H. Byeon, S.C. Lee, S.H. Choi, H.K. Lee, J.H. Lee, Y.K. Chu, O.W. Kwon, Vascular
endothelial growth factor as an autocrine survival factor for retinal pigment
epithelial cells under oxidative stress via the VEGF-R2/PI3K/Akt, Invest Ophthal-
mol. Vis Sci. 51 (2010) 1190–1197.
[35] M. Hollborn, A. Bringmann, F. Faude, P. Wiedemann, L. Kohen, Signaling pathways
involved in PDGF-evoked cellular responses in human RPE cells, Biochem.
Biophys. Res. Commun. 344 (2006) 912–919.
[36] S.W. Chung, J.W. Park, S.A. Lee, S.K. Eo, K. Kim, Thrombin promotes proin-
ﬂammatory phenotype in human vascular smooth muscle cell, Biochem. Biophys.
Res. Commun. 396 (2010) 748–754.
[37] D.R. Alessi, P. Cohen, Mechanism of activation and function of protein kinase B,
Curr. Opin. Genet. Dev. 8 (1998) 55–62.
[38] K. Yu, P. Ma, J. Ge, C.D. Willey, P. Yang, Z. Wang, Q. Gao, Expression of protein
kinase C isoforms in cultured human retinal pigment epithelial cells, Graefes Arch
Clin. Exp. Ophthalmol. 245 (2007) 993–999.
[39] S. Yano, H. Tokumitsu, T.R. Soderling, Calcium promotes cell survival through
CaM-K kinase activation of the protein-kinase-B pathway, Nature 396 (1998)
584–587.
[40] Y. Cheng, L. Yan, X. Ren, J.M. Yang, eEF-2 kinase, another meddler in the "Yin and
Yang" of Akt-mediated cell fate? Autophagy 7 (2011) 660–661.
[41] R. Goel, P.J. Phillips-Mason, D.M. Raben, J.J. Baldassare, alpha-Thrombin induces
rapid and sustained Akt phosphorylation by beta-arrestin1-dependent and
-independent mechanisms, and only the sustained Akt phosphorylation is
essential for G1 phase progression, J. Biol. Chem. 277 (2002) 18640–18648.
[42] F. Oriente, P. Formisano, C. Miele, F. Fiory, M.A. Maitan, G. Vigliotta, A. Trencia, S.
Santopietro, M. Caruso, E. Van Obberghen, F. Beguinot, Insulin receptor substrate-
2 phosphorylation is necessary for protein kinase C zeta activation by insulin in
L6hIR cells, J. Biol. Chem. 276 (2001) 37109–37119.
[43] R.W. Matheny Jr., M.L. Adamo, Current perspectives on Akt Akt-ivation and Akt-
ions, Exp. Biol. Med. (Maywood) 234 (2009) 1264–1270.
